药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Mecasermin
Motavizumab
The risk or severity of adverse effects can be increased when Motavizumab is combined with Brentuximab vedotin.
Mecasermin
Sonepcizumab
The risk or severity of adverse effects can be increased when Sonepcizumab is combined with Brentuximab vedotin.
Mecasermin
BIIB015
The risk or severity of adverse effects can be increased when BIIB015 is combined with Brentuximab vedotin.
Mecasermin
Clenoliximab
The risk or severity of adverse effects can be increased when Clenoliximab is combined with Brentuximab vedotin.
Mecasermin
Nimotuzumab
The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Brentuximab vedotin.
Mecasermin
Ipilimumab
The risk or severity of adverse effects can be increased when Ipilimumab is combined with Brentuximab vedotin.
Mecasermin
Lumiliximab
The risk or severity of adverse effects can be increased when Lumiliximab is combined with Brentuximab vedotin.
Mecasermin
Eldelumab
The risk or severity of adverse effects can be increased when Eldelumab is combined with Brentuximab vedotin.
Mecasermin
IMC-1C11
The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Brentuximab vedotin.
Mecasermin
Caplacizumab
The risk or severity of adverse effects can be increased when Caplacizumab is combined with Brentuximab vedotin.
Mecasermin
TB-402
The risk or severity of adverse effects can be increased when TB-402 is combined with Brentuximab vedotin.
Mecasermin
IPH 2101
The risk or severity of adverse effects can be increased when IPH 2101 is combined with Brentuximab vedotin.
Mecasermin
Olaratumab
The risk or severity of adverse effects can be increased when Olaratumab is combined with Brentuximab vedotin.
Mecasermin
Glembatumumab vedotin
The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Brentuximab vedotin.
Mecasermin
Leronlimab
The risk or severity of adverse effects can be increased when Leronlimab is combined with Brentuximab vedotin.
Mecasermin
CT-011
The risk or severity of adverse effects can be increased when CT-011 is combined with Brentuximab vedotin.
Mecasermin
MYO-029
The risk or severity of adverse effects can be increased when MYO-029 is combined with Brentuximab vedotin.
Mecasermin
RI 624
The risk or severity of adverse effects can be increased when RI 624 is combined with Brentuximab vedotin.
Mecasermin
TNX-901
The risk or severity of adverse effects can be increased when TNX-901 is combined with Brentuximab vedotin.
Mecasermin
PRO-542
The risk or severity of adverse effects can be increased when PRO-542 is combined with Brentuximab vedotin.